European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer: London, UK Tuesday, January 21, 2025, 09:0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback